Population Pharmacokinetic Study of Amoxicillin-Treated Burn Patients Hospitalized at a Swiss Tertiary-Care Center
Open Access
- 1 September 2018
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 62 (9)
Abstract
The objective of this study was to investigate the population pharmacokinetics (PK) of amoxicillin in ICU burn patients and the optimal dosage regimens. This was a prospective study involving 21 consecutive burn patients receiving amoxicillin.Keywords
This publication has 54 references indexed in Scilit:
- Amoxicillin Crystalluria, an Emerging Complication with an Old and Well-Known AntibioticAntimicrobial Agents and Chemotherapy, 2016
- How do we use therapeutic drug monitoring to improve outcomes from severe infections in critically ill patients?BMC Infectious Diseases, 2014
- DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?Clinical Infectious Diseases, 2014
- Population pharmacokinetics and dosing simulations of amoxicillin/clavulanic acid in critically ill patientsJournal of Antimicrobial Chemotherapy, 2013
- Cause of death and correlation with autopsy findings in burns patientsBurns, 2013
- PsN-Toolkit—A collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEMComputer Methods and Programs in Biomedicine, 2005
- Use of high-performance liquid chromatography (HPLC) to monitor β-lactam plasma concentrations during the treatment of endocarditisClinical Microbiology and Infection, 2005
- Pharmacokinetics of antibiotics in burn patientsJournal of Antimicrobial Chemotherapy, 1999
- GENERALIZED VASCULAR PERMEABILITY AND PULMONARY FUNCTION IN PATIENTS FOLLOWING SERIOUS TRAUMA1994
- Whole-Body Inflammation in Trauma PatientsArchives of Surgery, 1988